Join A&M Healthcare Industry Group's Marthe Haverkamp, M.D., Ph.D, as she sits down with world-renowned virologist Ab Osterhaus, Ph.D., and vaccine expert Manon Cox, Ph.D., MBA, Chief Executive Officer and Co-Founder of NextWaveBio. They discuss the future of vaccines, the value of COVID-19 treatments, and the influence of Omicron on the pandemic: Is a relatively mild disease now a comparative advantage for the future?
https://www.alvarezandmarsal.com/insights/is-omicron-our-way-out
Earlier this year, CMS finalized multiple rules that impact MAOs, with significant ramifications to procedures for RADV audits. Listen as A&M Healthcare Industry Group...
On this International Women’s Day, we are happy to share our latest Significant Healthcare Voices episode with an incredible leader, Coreen Dicus-Johnson, President &...
Part I: A look at HHS, the Latest COVID-19 Relief Bill and What the Next Two Years Means for Democrats and Republicans In this...
